Journal Homepage Image

Diabetes mellitus

Since 1998 the “Diabetes Mellitus” (or “Sakharni Diabet”) Journal publishes timely articles, balancing both clinical and experimental research, case reports, reviews and lectures on pressing problems of diabetology. The Journal is aimed to provide a forum to discuss etiology and pathogenesis, clinical features, modern diagnostic and treatment approaches to diabetes mellitus and its complications, as well as associated conditions.

 The Journal:

  • features original national and foreign research articles, reflecting world diabetology development
  • issues thematic editions on specific areas (diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, etc.);
  • publishes chronicle of major international congress sessions and workshops on diabetes mellitus, as well as state-of-the-art guidelines;
  • is intended for scientists, diabetologists, endocrinologists and specialists of allied trade, general practitioners, family physicians and pediatricians.

The “Diabetes Mellitus” Journal is included into the “List of leading scientific peer-reviewed journals, where principal data of applicants for scientific degree has to be published”, as decreed by State Commission for Academic Degrees and Titles in Bulletin №2 of 2003 and revised in 2010.

The Diabetes Mellitus journal is currently indexed in Scopus (Elsevier), Emerging Sources Citation Index (Web of Science, Thomson Reuters), Google Scholar and Russian Science Citation Index.

All articles in the Diabetes Mellitus journal are published in Open Access (Gold) format with Free Full-text access to all articles via several websites ( and mobile applications for iOS® (available in AppStore).

The journal is open for Russian and English language manuscripts. All English language manuscripts are published in bilingual format. Electronic full-text versions of all articles are available in both Russian and English, while print version features only texts in Russian. Click here to know more.




News: An overview of the 77 American Diabetes Association congress


This short message is to overview the main points of 77 American Diabetes Association congress (in russian for russian-speaking auditory).

Posted: 13.08.2017 More...

News: Invocana® (cannagliflozin) significantly reduces combined risk of cardiovascular death, heart attack myocardium and stroke according to the CANVAS program


This short message is for review the primary data previously published in New England Journal of Medicine - in russian for russian-speaking auditory.

Posted: 13.08.2017 More...

New issue: The new issue of Diabetes Mellitus journal is published


The new issue of "Diabetes Mellitus" journal [volume 20 issue 3] is available now 

Posted: 13.08.2017 More...
More Announcements...

Current Issue

Vol 20, No 3 (2017)

Study of the associations between polymorphic markers rs1800629 TNFa, rs909253 Lta, rs767455 TNFR1, rs1061624 TNFR2 and the development of type 2 diabetes
Churnosov M.I., Belousova O.N., Sirotina S.S.
Diabetes mellitus. 2017;20(3):166-171
Education and psychosociologycal aspects
Insulin resistance and its possible personal stress moderators
Motovilin O.G., Surkova E.V., Mayorov A.Y., Koksharova E.O., Melnikova O.G.
Diabetes mellitus. 2017;20(3):172-180
Tauopathy and cognitive impairment in experimental diabetes mellitus
Matveeva M.V., SamoiIova Y.G., Zhukova N.G., Oleynik O.A., Rotkank M.A.
Diabetes mellitus. 2017;20(3):181-184
Predictors and diagnosis of cardiac autonomic nervous dysfunction in patients with type 1 and type 2 diabetes mellitus
Popov K.A., Tokmakova A.Y., Bondarenko I.Z.
Diabetes mellitus. 2017;20(3):185-193
Lipid profile and markers of vascular inflammation in patients with stable angina in the presence and absence of type 2 diabetes mellitus
Petelina T.I., Musikhina N.A., Gapom L.I., Емеneva I.V., Gorbatenko E.A.
Diabetes mellitus. 2017;20(3):194-200
Diagnosis, control, treatment
Evolution of biliopancreatic diversion in the treatment of morbid obesity and type 2 diabetes mellitus
Bordan N.S., Yashkov Y.I.
Diabetes mellitus. 2017;20(3):201-209
Multidimensional effects of metformin in patients with type 2 diabetes
Ruyatkina L.A., Ruyatkin D.S.
Diabetes mellitus. 2017;20(3):210-219
Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies
Shestakova M.V., Yudovich E.A.
Diabetes mellitus. 2017;20(3):220-230
In memory of Professor Sagdulla A. Abusuev
Diabetes mellitus. 2017;20(3):231-232
Regulatory documents
Expert council resolution on regional program of early T2D detection, prevention and treatment in Russian Federation
Shestakova M.V., Drapkina O.M., Boitsov S.A., Drozdova L.Y., Mayorov A.Y., Galstyan G.R., Sukhareva O.Y.
Diabetes mellitus. 2017;20(3):233-237